Primarily used in the management of type 2 diabetes, this compound acts as an alpha-glucosidase inhibitor, effectively slowing down carbohydrate digestion and absorption in the intestines. This helps in controlling postprandial blood sugar levels. Additionally, it has shown potential in antiviral applications, particularly against certain strains of influenza and HIV, by interfering with viral glycoprotein processing. Research is also exploring its use in combating obesity and metabolic syndrome due to its ability to modulate glucose metabolism. In the field of oncology, preliminary studies suggest it may inhibit tumor growth by affecting glycosylation processes crucial for cancer cell proliferation. Its role in neuroprotection is also under investigation, with studies indicating possible benefits in neurodegenerative diseases like Alzheimer’s by reducing amyloid-beta production.